PUBLISHER: Grand View Research | PRODUCT CODE: 2040467
PUBLISHER: Grand View Research | PRODUCT CODE: 2040467
The global veterinary parasiticides market size was estimated at USD 10.9 billion in 2025 and is projected to reach USD 24.5 billion by 2033, growing at a CAGR of 10.8% from 2026 to 2033. Some of the factors driving the market growth are regulatory approvals for long-acting parasiticides, sustained innovation by leading animal health companies, rising awareness of parasite prevention in companion animals, and growing parasite burden and livestock productivity requirements.
The increasing burden of parasitic infections in livestock continues to drive consistent demand for veterinary parasiticides across production animal segments. Gastrointestinal nematodes, ticks, mites, and other internal parasites remain prevalent across cattle, sheep, goats, and pigs. These infections directly reduce feed conversion efficiency, weight gain, milk yield, and reproductive performance. As a result, producers are maintaining routine parasite control protocols to protect output and limit production losses. In grazing systems, parasite exposure remains closely linked to pasture management and stocking density. Higher stocking intensity increases contamination of grazing land with infective larvae, leading to repeated reinfection cycles.
Moreover, parasite control in grazing animals is becoming more structured, with veterinarians, farmers, and advisors sharing diagnostic data, treatment history, and grazing patterns to improve intervention timing and product selection. This coordinated approach is strengthening the adoption of scheduled deworming and integrated parasite management practices across ruminant production systems.
Furthermore, the economic burden associated with parasitic infections remains substantial at the farm level. Infected livestock exhibit reduced appetite, impaired nutrient absorption, and weakened immunity, increasing the risk of secondary infections. In dairy operations, this leads to lower milk yield and quality. In meat production systems, slower growth rates and reduced carcass weight affect profitability.
In addition, specific parasitic infestations, such as screwworm in cattle, are associated with severe tissue damage and high treatment costs, which increase the need for targeted parasiticides. Recent product approvals for cattle addressing such infestations indicate continued focus on mitigating high-impact parasitic threats in production animals. Anthelmintic resistance is further shaping treatment strategies across livestock segments. Resistance to widely used drug classes has been reported across ruminant species, driving the use of rotation strategies and combination therapies. This is increasing dependence on veterinary oversight for treatment planning and efficacy monitoring. Consequently, producers are adopting more controlled and frequent parasite management programs to maintain productivity levels.
In addition, product innovation is aligning with livestock productivity requirements. Manufacturers are introducing longer-acting formulations and convenient delivery systems that reduce dosing frequency and labor requirements. For instance, in November 2025, Merck received approval for its long-acting injectable, Bravecto Quantum, providing up to 12 months of protection in dogs, reducing dosing frequency and improving compliance. Extended-duration parasiticides, including injectables and sustained-release formulations, are supporting compliance in large herd settings and enabling consistent parasite control across production cycles. This is particularly relevant in regions with high parasite prevalence, where continuous protection is required to maintain herd health.
Livestock productivity targets continue to shape purchasing behavior. Producers are prioritizing parasiticides that offer broad-spectrum efficacy, extended duration, and ease of administration across large herds. Oral, injectable, and topical routes are selected based on operational efficiency and animal type. This sustained focus on productivity, combined with rising parasite pressure and evolving resistance patterns, is expected to maintain steady demand for veterinary parasiticides across global production animal segments.
Global Veterinary Parasiticides Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary parasiticides market report based on product, animal, route of administration, type, distribution channel, and region: